Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 61

1.

[Epigenetic regulation during osteoclastogenesis].

Youn MY, Kato S, Imai Y.

Clin Calcium. 2012 May;22(5):611-7. doi: CliCa1205611617. Review. Japanese.

PMID:
22549184
2.

[Epigenetic regulation of osteoclastogenesis by histone modification].

Omata Y, Tanaka S.

Clin Calcium. 2012 May;22(5):619-28. doi: CliCa1205619628. Review. Japanese.

PMID:
22549185
3.

Autoamplification of NFATc1 expression determines its essential role in bone homeostasis.

Asagiri M, Sato K, Usami T, Ochi S, Nishina H, Yoshida H, Morita I, Wagner EF, Mak TW, Serfling E, Takayanagi H.

J Exp Med. 2005 Nov 7;202(9):1261-9.

4.

Blimp1-mediated repression of negative regulators is required for osteoclast differentiation.

Nishikawa K, Nakashima T, Hayashi M, Fukunaga T, Kato S, Kodama T, Takahashi S, Calame K, Takayanagi H.

Proc Natl Acad Sci U S A. 2010 Feb 16;107(7):3117-22. doi: 10.1073/pnas.0912779107.

5.

Epigenetic regulation of osteoclast differentiation: possible involvement of Jmjd3 in the histone demethylation of Nfatc1.

Yasui T, Hirose J, Tsutsumi S, Nakamura K, Aburatani H, Tanaka S.

J Bone Miner Res. 2011 Nov;26(11):2665-71. doi: 10.1002/jbmr.464.

6.

NFATc1: functions in osteoclasts.

Zhao Q, Wang X, Liu Y, He A, Jia R.

Int J Biochem Cell Biol. 2010 May;42(5):576-9. doi: 10.1016/j.biocel.2009.12.018. Review.

PMID:
20035895
7.

RGS18 acts as a negative regulator of osteoclastogenesis by modulating the acid-sensing OGR1/NFAT signaling pathway.

Iwai K, Koike M, Ohshima S, Miyatake K, Uchiyama Y, Saeki Y, Ishii M.

J Bone Miner Res. 2007 Oct;22(10):1612-20.

8.

Interleukin-4 inhibits RANKL-induced expression of NFATc1 and c-Fos: a possible mechanism for downregulation of osteoclastogenesis.

Kamel Mohamed SG, Sugiyama E, Shinoda K, Hounoki H, Taki H, Maruyama M, Miyahara T, Kobayashi M.

Biochem Biophys Res Commun. 2005 Apr 15;329(3):839-45.

PMID:
15752732
9.

T-cell leukemia translocation-associated gene (TCTA) protein is required for human osteoclastogenesis.

Kotake S, Nanke Y, Kawamoto M, Yago T, Udagawa N, Ichikawa N, Kobashigawa T, Saito S, Momohara S, Kamatani N, Yamanaka H.

Bone. 2009 Oct;45(4):627-39. doi: 10.1016/j.bone.2009.06.019.

PMID:
19560569
10.

The molecular understanding of osteoclast differentiation.

Asagiri M, Takayanagi H.

Bone. 2007 Feb;40(2):251-64. Review.

PMID:
17098490
11.

Myocyte enhancer factor 2 and microphthalmia-associated transcription factor cooperate with NFATc1 to transactivate the V-ATPase d2 promoter during RANKL-induced osteoclastogenesis.

Feng H, Cheng T, Steer JH, Joyce DA, Pavlos NJ, Leong C, Kular J, Liu J, Feng X, Zheng MH, Xu J.

J Biol Chem. 2009 May 22;284(21):14667-76. doi: 10.1074/jbc.M901670200.

12.

Induction of DC-STAMP by alternative activation and downstream signaling mechanisms.

Yagi M, Ninomiya K, Fujita N, Suzuki T, Iwasaki R, Morita K, Hosogane N, Matsuo K, Toyama Y, Suda T, Miyamoto T.

J Bone Miner Res. 2007 Jul;22(7):992-1001.

13.

Epigenetic regulation of osteoclast differentiation.

Yasui T, Hirose J, Aburatani H, Tanaka S.

Ann N Y Acad Sci. 2011 Dec;1240:7-13. doi: 10.1111/j.1749-6632.2011.06245.x. Review.

PMID:
22172033
14.

Regulators of osteoclast differentiation and cell-cell fusion.

Miyamoto T.

Keio J Med. 2011;60(4):101-5. Review.

15.

The small molecule harmine regulates NFATc1 and Id2 expression in osteoclast progenitor cells.

Egusa H, Doi M, Saeki M, Fukuyasu S, Akashi Y, Yokota Y, Yatani H, Kamisaki Y.

Bone. 2011 Aug;49(2):264-74. doi: 10.1016/j.bone.2011.04.003.

PMID:
21504804
16.

Interleukin-10 inhibits RANKL-mediated expression of NFATc1 in part via suppression of c-Fos and c-Jun in RAW264.7 cells and mouse bone marrow cells.

Mohamed SG, Sugiyama E, Shinoda K, Taki H, Hounoki H, Abdel-Aziz HO, Maruyama M, Kobayashi M, Ogawa H, Miyahara T.

Bone. 2007 Oct;41(4):592-602.

PMID:
17627913
17.

Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts.

Takayanagi H, Kim S, Koga T, Nishina H, Isshiki M, Yoshida H, Saiura A, Isobe M, Yokochi T, Inoue J, Wagner EF, Mak TW, Kodama T, Taniguchi T.

Dev Cell. 2002 Dec;3(6):889-901.

18.

Trichostatin A inhibits osteoclastogenesis and bone resorption by suppressing the induction of c-Fos by RANKL.

Kim HN, Ha H, Lee JH, Jung K, Yang D, Woo KM, Lee ZH.

Eur J Pharmacol. 2009 Nov 25;623(1-3):22-9. doi: 10.1016/j.ejphar.2009.09.025.

PMID:
19766111
19.

GM-CSF regulates fusion of mononuclear osteoclasts into bone-resorbing osteoclasts by activating the Ras/ERK pathway.

Lee MS, Kim HS, Yeon JT, Choi SW, Chun CH, Kwak HB, Oh J.

J Immunol. 2009 Sep 1;183(5):3390-9. doi: 10.4049/jimmunol.0804314.

20.

Adenylate cyclase and calmodulin-dependent kinase have opposite effects on osteoclastogenesis by regulating the PKA-NFATc1 pathway.

Yoon SH, Ryu Jy, Lee Y, Lee ZH, Kim HH.

J Bone Miner Res. 2011 Jun;26(6):1217-29. doi: 10.1002/jbmr.310.

Items per page

Supplemental Content

Support Center